Sample Terms of Service
A sample terms of service agreement between an individual and a company concerning the use of the company's website. This agreement includes clauses for license grants, restrictions, user obligations, privacy, and postings.
A sample terms of service agreement between an individual and a company concerning the use of the company's website. This agreement includes clauses for license grants, restrictions, user obligations, privacy, and postings.
These template website terms of use are intended for use on non-transactional, information-based websites. The terms of use are not intended for use on websites through which users can place orders for or buy goods, services or digital products. If the website permits User Generated Content (UGC), then additional "acceptable use" terms will be needed, for example, a user's undertaking that he/she will not post UGC that is defamatory, infringing or illegal, and details of the website operator's notice-and-take-action procedures.
This is a glossary of Information Governance terms.
This is a checklist of steps organizations could take to minimize the chance and impact of a successful ransomware attack, and to be prepared to respond.
This is a sample agreement between a vendor company and a client company for the design, development and manufacturing of a system (sample agreement governed by the laws of the State of New Jersey).
This is a sample copyright assignment agreement, under which a marketing firm that was hired by a company to create a logo assigns the copyright to the logo to the client company.
Canada is an attractive market for pharmaceutical manufacturers. Most Canadian consumers have some form of drug coverage through government programs and/or private insurance. Below are ten patent and regulatory topics that in-house counsel need to know before bringing an innovative product to Canada.
Editor's note: This article was updated to reflect recent developments; the original version of this article was published on December 16, 2020.
The September 2017 amendments to the Patented Medicines (Notice of Compliance) Regulations introduced a new scheme for pharmaceutical patent linkage litigation in Canada. That scheme is now much closer to the United States' (US) Hatch-Waxman scheme, but with remaining key differences that are explained in this chart.
Amendments to the Canadian Patent Act and enactment of the Certificate of Supplementary Protection Regulations flowing from the Canada-European Union (EU) Comprehensive Economic and Trade Agreement introduced a new framework in Canada for the issuance of Certificates of Supplementary Protection (CSPs).
This chart compare key aspects of the two regimes, Canada's and the EU's.
This sample form is for use in the assignment of a utility patent application and related intellectual property rights, from an inventor to a corporation.